A carregar...

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

Yayi He,1,2,* Sangtian Liu,1,* Jane Mattei,3 Paul A Bunn Jr,2 Caicun Zhou,1 Daniel Chan2 1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China; 2Division of Medical Oncology, Department...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: He YY, Liu ST, Mattei J, Bunn Jr PA, Zhou CC, Chan D
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018-04-01
Colecção:Drug Design, Development and Therapy
Assuntos:
Acesso em linha:https://www.dovepress.com/the-combination-of-anti-kir-monoclonal-antibodies-with-anti-pd-1pd-l1--peer-reviewed-article-DDDT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!